{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:29:17Z","timestamp":1794475757634,"version":"4.9.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ygyno.2026.05.004","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:36:21Z","timestamp":1778592981000},"page":"88-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Endometriosis and ovarian cancer risk"],"prefix":"10.1016","volume":"209","author":[{"given":"Giorgio","family":"Bogani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen N.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Ray-Coquard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Ceccaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Fotopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Mabrouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh S.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horace","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo A.","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailesh","family":"Puntambekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Malzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaby N.","family":"Moawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio S.","family":"Abr\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Chiappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Vizzielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Raspagliesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainhoa","family":"Madariaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Slomovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Amant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley J.","family":"Monk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith R.","family":"Kroep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10276","key":"10.1016\/j.ygyno.2026.05.004_bb0005","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(21)00389-5","article-title":"Endometriosis is a chronic systemic disease: clinical challenges and novel innovations","volume":"397","author":"Taylor","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ygyno.2026.05.004_bb0010","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41588-023-01323-z","article-title":"The genetic basis of endometriosis and comorbidity with other pain and inflammatory conditions","volume":"55","author":"Rahmioglu","year":"2023","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.ygyno.2026.05.004_bb0015","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.fertnstert.2008.08.007","article-title":"The relationship of endometriosis and ovarian malignancy: a review","volume":"90","author":"Nezhat","year":"2008","journal-title":"Fertil. Steril."},{"issue":"6","key":"10.1016\/j.ygyno.2026.05.004_bb0020","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jama.2024.9210","article-title":"Endometriosis typology and ovarian Cancer risk","volume":"332","author":"Barnard","year":"2024","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ygyno.2026.05.004_bb0025","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ygyno.2021.06.033","article-title":"Clear cell carcinoma of the ovary: epidemiology, pathological and biological features, treatment options and clinical outcomes","volume":"162","author":"Gadducci","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"23","key":"10.1016\/j.ygyno.2026.05.004_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13236062","article-title":"Therapeutic influence on important targets associated with chronic inflammation and oxidative stress in cancer treatment","volume":"13","author":"Neganova","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ygyno.2026.05.004_bb0035","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/PGP.0000000000000952","article-title":"Atypical endometriosis: comprehensive characterization of clinicopathologic, immunohistochemical, and molecular features","volume":"43","author":"Wepy","year":"2024","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.05.004_bb0040","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2005.11.033","article-title":"Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence","volume":"101","author":"Somigliana","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.05.004_bb0045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bpobgyn.2018.01.017","article-title":"Perimenopausal management of ovarian endometriosis and associated cancer risk: when is medical or surgical treatment indicated?","volume":"51","author":"Vercellini","year":"2018","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"4","key":"10.1016\/j.ygyno.2026.05.004_bb0050","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1470-2045(11)70404-1","article-title":"Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies","volume":"13","author":"Pearce","year":"2012","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.05.004_bb0055","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/humupd\/dmaa045","article-title":"Endometriosis and cancer: a systematic review and meta-analysis","volume":"27","author":"Kvaskoff","year":"2021","journal-title":"Hum. Reprod. Update"},{"issue":"5","key":"10.1016\/j.ygyno.2026.05.004_bb0060","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/humrep\/dei462","article-title":"Endometriosis and the risk of cancer with special emphasis on ovarian cancer","volume":"21","author":"Melin","year":"2006","journal-title":"Hum. Reprod."},{"issue":"11","key":"10.1016\/j.ygyno.2026.05.004_bb0065","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/humrep\/dem209","article-title":"The risk of cancer and the role of parity among women with endometriosis","volume":"22","author":"Melin","year":"2007","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.ygyno.2026.05.004_bb0070","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00001648-200003000-00006","article-title":"Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer","volume":"11","author":"Ness","year":"2000","journal-title":"Epidemiology"},{"issue":"3","key":"10.1016\/j.ygyno.2026.05.004_bb0075","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/aje\/155.3.217","article-title":"Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies","volume":"155","author":"Ness","year":"2002","journal-title":"Am. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.ygyno.2026.05.004_bb0080","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/cncr.10370","article-title":"Postmenopausal cancer risk after self-reported endometriosis diagnosis in the Iowa women\u2019s health study","volume":"94","author":"Olson","year":"2002","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2026.05.004_bb0085","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajog.2004.03.035","article-title":"Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis","volume":"191","author":"Modugno","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.ygyno.2026.05.004_bb0090","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.0001-6349.2004.00305.x","article-title":"Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis","volume":"83","author":"Borgfeldt","year":"2004","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.ygyno.2026.05.004_bb0095","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.fertnstert.2004.02.109","article-title":"Ovarian cancer risk associated with varying causes of infertility","volume":"82","author":"Brinton","year":"2004","journal-title":"Fertil. Steril."},{"issue":"12","key":"10.1016\/j.ygyno.2026.05.004_bb0100","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1158\/1055-9965.EPI-05-0394","article-title":"Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors","volume":"14","author":"Brinton","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"1","key":"10.1016\/j.ygyno.2026.05.004_bb0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1525-1438.2006.00754.x","article-title":"Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan","volume":"17","author":"Kobayashi","year":"2007","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2026.05.004_bb0110","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.fertnstert.2009.07.1698","article-title":"Cancers, infections, and endocrine diseases in women with endometriosis","volume":"94","author":"Gemmill","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ygyno.2026.05.004_bb0115","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1757-2215-3-2","article-title":"Endometriosis-associated ovarian cancer: a ten year cohort study of women living in the Estrie region of Quebec, Canada","volume":"19","author":"Aris","year":"2010","journal-title":"J. Ovarian Res."},{"issue":"2","key":"10.1016\/j.ygyno.2026.05.004_bb0120","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ygyno.2011.06.038","article-title":"Use of metformin and the risk of ovarian cancer: a case-control analysis","volume":"123","author":"Bodmer","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.05.004_bb0125","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ygyno.2012.10.023","article-title":"In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk","volume":"128","author":"Stewart","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2026.05.004_bb0130","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1093\/humrep\/det340","article-title":"Burger CW; OMEGA project group. Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis","volume":"28","author":"Buis","year":"2013","journal-title":"Hum. Reprod."},{"issue":"4","key":"10.1016\/j.ygyno.2026.05.004_bb0135","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.tjog.2014.04.025","article-title":"Endometriosis and the subsequent risk of epithelial ovarian cancer","volume":"53","author":"Chang","year":"2014","journal-title":"Taiwan. J. Obstet. Gynecol."},{"issue":"14","key":"10.1016\/j.ygyno.2026.05.004_bb0140","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1186\/1471-2407-14-831","article-title":"An increased risk of epithelial ovarian cancer in Taiwanese women with a new surgico-pathological diagnosis of endometriosis","volume":"18","author":"Wang","year":"2014","journal-title":"BMC Cancer"},{"issue":"15","key":"10.1016\/j.ygyno.2026.05.004_bb0145","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1186\/s12885-015-1821-9","article-title":"Endometriosis as a risk factor for ovarian or endometrial cancer - results of a hospital-based case-control study","volume":"21","author":"Burghaus","year":"2015","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2026.05.004_bb0150","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/IGC.0000000000000454","article-title":"The risks for ovarian, endometrial, breast, colorectal, and other cancers in women with newly diagnosed endometriosis or adenomyosis: a population-based study","volume":"25","author":"Kok","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2026.05.004_bb0155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ygyno.2016.07.095","article-title":"Endometriosis and risks for ovarian, endometrial and breast cancers: a nationwide cohort study","volume":"143","author":"Mogensen","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.05.004_bb0160","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejogrb.2016.07.494","article-title":"Epithelial ovarian cancer and type of peritoneal insult: a case-control study","volume":"205","author":"Ruiz","year":"2016","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"24","key":"10.1016\/j.ygyno.2026.05.004_bb0165","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1200\/JCO.2016.66.8178","article-title":"Ovarian cancer risk factors by histologic subtype: An analysis from the Ovarian Cancer Cohort Consortium","volume":"34","author":"Wentzensen","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2026.05.004_bb0170","first-page":"393","article-title":"Hormonal and reproductive factors and the risk of ovarian cancer","volume":"28","author":"Koushik","year":"2017","journal-title":"Cancer Causes Control"},{"issue":"5","key":"10.1016\/j.ygyno.2026.05.004_bb0175","first-page":"437","article-title":"Endometriosis and risk of ovarian and endometrial cancers in a large prospective cohort of U.S. nurses","volume":"28","author":"Poole","year":"2017","journal-title":"Cancer Causes Control"},{"issue":"6","key":"10.1016\/j.ygyno.2026.05.004_bb0180","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/AOG.0000000000002624","article-title":"Risk of Gynecologic Cancer according to the type of endometriosis","volume":"131","author":"Saavalainen","year":"2018","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.05.004_bb0185","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/1471-0528.14793","article-title":"Impact of endometriosis on risk of further gynaecological surgery and cancer: a national cohort study","volume":"125","author":"Saraswat","year":"2018","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.ygyno.2026.05.004_bb0190","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ygyno.2012.10.023","article-title":"In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk","volume":"128","author":"Stewart","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2026.05.004_bb0195","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1089\/jwh.2017.6432","article-title":"Risk of developing comorbidities among women with endometriosis: a retrospective matched cohort study","volume":"27","author":"Surrey","year":"2018","journal-title":"J. Women\u2019s Health (Larchmt)"},{"key":"10.1016\/j.ygyno.2026.05.004_bb0200","article-title":"Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation","volume":"362","author":"Williams","year":"2018","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.ygyno.2026.05.004_bb0205","first-page":"1081","article-title":"Benign gynecologic conditions are associated with ovarian cancer risk in African-American women: a case-control study","volume":"29","author":"Park","year":"2018","journal-title":"Cancer Causes Control"},{"issue":"11","key":"10.1016\/j.ygyno.2026.05.004_bb0210","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1093\/humrep\/dez165","article-title":"Assisted reproductive technology treatment and risk of ovarian cancer-a nationwide population-based cohort study","volume":"34","author":"Vassard","year":"2019","journal-title":"Hum. Reprod."},{"issue":"18","key":"10.1016\/j.ygyno.2026.05.004_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16183469","article-title":"Risk of endometriosis and subsequent ovary and breast cancers in nurses: a population-based cohort study in Taiwan","volume":"16","author":"Hsu","year":"2019","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"5","key":"10.1016\/j.ygyno.2026.05.004_bb0220","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10654-018-0474-9","article-title":"The risk of breast and gynecological cancer in women with a diagnosis of infertility: a nationwide population-based study","volume":"34","author":"Lundberg","year":"2019","journal-title":"Eur. J. Epidemiol."},{"issue":"19","key":"10.1016\/j.ygyno.2026.05.004_bb0225","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1056\/NEJMoa1614814","article-title":"Cancer-associated mutations in endometriosis without cancer","volume":"376","author":"Anglesio","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2026.05.004_bb0230","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/humupd\/dmi037","article-title":"Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis","volume":"12","author":"Vigan\u00f3","year":"2006","journal-title":"Hum. Reprod. Update"},{"issue":"12","key":"10.1016\/j.ygyno.2026.05.004_bb0235","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/molehr\/4.12.1150","article-title":"Expression of intercellular adhesion molecule (ICAM)-1 mRNA and protein is enhanced in endometriosis versus endometrial stromal cells in culture","volume":"4","author":"Vigan\u00f2","year":"1998","journal-title":"Mol. Hum. Reprod."},{"issue":"16","key":"10.1016\/j.ygyno.2026.05.004_bb0240","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2026.05.004_bb0245","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bpobgyn.2018.01.012","article-title":"Genetics of endometriosis: state of the art on genetic risk factors for endometriosis","volume":"50","author":"Fung","year":"2018","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"4","key":"10.1016\/j.ygyno.2026.05.004_bb0250","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.fertnstert.2015.06.029","article-title":"Circulating miR-200-family micro-RNAs have altered plasma levels in patients with endometriosis and vary with blood collection time","volume":"104","author":"Rekker","year":"2015","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.ygyno.2026.05.004_bb0255","first-page":"155","article-title":"The role of toll-like receptor 9 in gynecologic cancer","volume":"64","author":"Fehri","year":"2016","journal-title":"Curr. Res. Transl. Med."},{"issue":"5","key":"10.1016\/j.ygyno.2026.05.004_bb0260","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrendo.2013.255","article-title":"Endometriosis: pathogenesis and treatment","volume":"10","author":"Vercellini","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"10.1016\/j.ygyno.2026.05.004_bb0265","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ijgc-2020-001656","article-title":"Clear cell carcinoma of the ovary: a clinical and molecular perspective","volume":"31","author":"Iida","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2026.05.004_bb0270","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/humupd\/dmy014","article-title":"Non-coding RNAs in endometriosis: a narrative review","volume":"24","author":"Panir","year":"2018","journal-title":"Hum. Reprod. Update"},{"issue":"2","key":"10.1016\/j.ygyno.2026.05.004_bb0275","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.fertnstert.2023.12.008","article-title":"Noninvasive diagnostic imaging for endometriosis part 1: a systematic review of recent developments in ultrasound, combination imaging, and artificial intelligence","volume":"121","author":"Avery","year":"2024","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.ygyno.2026.05.004_bb0280","doi-asserted-by":"crossref","first-page":"e233482","DOI":"10.1148\/radiol.233482","article-title":"Radiology state-of-the-art review: endometriosis imaging interpretation and reporting","volume":"312","author":"Van Buren","year":"2024","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.ygyno.2026.05.004_bb0285","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.1007\/s13277-014-1945-6","article-title":"HE4, CA125 and ROMA algorithm for differential diagnosis between benign gynaecological diseases and ovarian cancer","volume":"35","author":"Ortiz-Mu\u00f1oz","year":"2014","journal-title":"Tumour Biol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.05.004_bb0290","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ygyno.2016.01.016","article-title":"HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: an Italian multicenter study","volume":"141","author":"Romagnolo","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.05.004_bb0295","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4161\/rna.5.3.6558","article-title":"The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis","volume":"5","author":"Korpal","year":"2008","journal-title":"RNA Biol."},{"issue":"24","key":"10.1016\/j.ygyno.2026.05.004_bb0300","doi-asserted-by":"crossref","first-page":"11816","DOI":"10.3390\/ijms262411816","article-title":"From inflammation to malignancy: the link between endometriosis and gynecological cancers","volume":"26","author":"K\u0142odnicka","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ygyno.2026.05.004_bb0305","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3390\/jcm9061915","article-title":"Epithelial-mesenchymal transition in endometriosis-when does it happen?","volume":"9","author":"Konrad","year":"2020","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.ygyno.2026.05.004_bb0310","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/aogs.14462","article-title":"The application of risk models based on machine learning to predict endometriosis-associated ovarian cancer in patients with endometriosis","volume":"101","author":"Chao","year":"2022","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"1","key":"10.1016\/j.ygyno.2026.05.004_bb0315","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ygyno.2018.08.005","article-title":"Surgical prevention strategies in ovarian cancer","volume":"151","author":"Mallen","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2026.05.004_bb0320","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ejso.2019.11.517","article-title":"Endometriosis-associated ovarian cancer is not a distinct clinical entity among young patients: a 12-year cohort study","volume":"46","author":"Cai","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"issue":"10)","key":"10.1016\/j.ygyno.2026.05.004_bb0325","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/jog.16089","article-title":"Rethinking the pathogenesis of endometriosis: complex interactions of genomic, epigenetic, and environmental factors","volume":"50","author":"Kobayashi","year":"2024","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"3","key":"10.1016\/j.ygyno.2026.05.004_bb0330","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1158\/1541-7786.MCR-11-0177","article-title":"WNT7A regulates tumor growth and progression in ovarian cancer through the WNT\/\u03b2-catenin pathway","volume":"10","author":"Yoshioka","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ygyno.2026.05.004_bb0335","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ygyno.2022.10.020","article-title":"Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma","volume":"169","author":"Ackroyd","year":"2023","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2026.05.004_bb0340","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3390\/cells13040345","article-title":"Complexity of the genetic background of oncogenesis in ovarian cancer-genetic instability and clinical implications","volume":"13","author":"Murawski","year":"2024","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.ygyno.2026.05.004_bb0345","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.7150\/thno.52190","article-title":"Hypoxia-induced Nur77 activates PI3K\/Akt signaling via suppression of dicer\/let-7i-5p to induce epithelial-to-mesenchymal transition","volume":"11","author":"Shi","year":"2021","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.ygyno.2026.05.004_bb0350","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ijgo.12861","article-title":"The effect of concurrent endometriosis on the prognosis of women with ovarian clear cell or endometrioid carcinoma","volume":"146","author":"Ju","year":"2019","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"1","key":"10.1016\/j.ygyno.2026.05.004_bb0355","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13048-018-0425-9","article-title":"Endometriosis does not confer improved prognosis in ovarian clear cell carcinoma: a retrospective study at a single institute","volume":"11","author":"Zhao","year":"2018","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.ygyno.2026.05.004_bb0360","series-title":"ClinicalTrials.gov","author":"NIH. National Library of medicine","year":"2025"},{"key":"10.1016\/j.ygyno.2026.05.004_bb0365","series-title":"A Phase II Study of Tazemetostat (EPZ-6438) (IND # 138671) in Recurrent or Persistent Endometrioid or Clear Cell Carcinoma of the Ovary, and Recurrent or Persistent Endometrioid Endometrial Adenocarcinoma","author":"NRG Oncology","year":"2025"},{"issue":"1","key":"10.1016\/j.ygyno.2026.05.004_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.100814","article-title":"ATR inhibitor alone (ceralasertib) or in combination with olaparib in gynaecological cancers with ARID1A loss or no loss: results from the ENGOT\/GYN1\/NCRI ATARI trial","volume":"8","author":"Banerjee","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.ygyno.2026.05.004_bb0375","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1200\/JCO.2023.41.16_suppl.3094","article-title":"EZH2\/EZH1 inhibitor tulmimetostat (CPI-0209) in patients with advanced solid tumors or hematologic malignancies: preliminary phase II results","volume":"41","author":"Drescher","year":"2023","journal-title":"JCO"},{"issue":"3","key":"10.1016\/j.ygyno.2026.05.004_bb0380","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ygyno.2016.07.092","article-title":"Combined inhibition of PI3K and PARP is effective in the treatment of ovarian cancer cells with wild-type PIK3CA genes","volume":"142","author":"Wang","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.05.004_bb0385","article-title":"Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE\/APGOT-OV7\/ENGOT-ov80)","author":"Lee","year":"2024","journal-title":"J. Gynecol. Oncol."}],"updated-by":[{"DOI":"10.1016\/j.ygyno.2026.05.029","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000}}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826019797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826019797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:59:35Z","timestamp":1794473975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825826019797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":77,"alternative-id":["S0090825826019797"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.05.004","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endometriosis and ovarian cancer risk","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}